Based on KFF analysis of Medicare data from 2020, an estimated 7% of Medicare beneficiaries, or 3.6 million overall, had established cardiovascular disease and obesity or overweight in 2020, and so could be eligible for Medicare coverage of Wegovy for its new indication (Figure 1) (see Methods for details)
Treatment Duration: The length of time you are using semaglutide GLP-1 may influence the total cost, as some providers or programs may offer discounts for long-term use
Without that signal, the body is happy to catabolize muscle along with fat to meet its energy needs during a caloric deficit
The Verdict Who Should Consider the Pill
In 2022, the company that owns the patent of Eriomin funded a small clinical trial involving 45 people, concluding that those who took it over a 12-week period had lower blood glucose and higher GLP-1 than those who took a placebo
Semaglutide works because of its chemical structure